GH Research PLC Ordinary Shares (GHRS)
GH Research PLC Ordinary Shares (GHRS) is listed on Nasdaq, where it has traded since June 25, 2021.
- Listed On
- Nasdaq
- Listed Since
- June 25, 2021
- Employees
- 73
- Market Cap
- $1.4B
About GH Research PLC Ordinary Shares
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 61 institutions reported holding GHRS, with 51.5 million shares worth $1.4 billion in aggregate. The largest reported holder was Lynx1 Capital Management, with 13.3 million shares worth $356.5 million. Of the 5 largest holders listed below, 2 added shares, 1 reduced its position and 2 held their positions unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Lynx1 Capital Management | 13,263,288 | $357M | Added 23.23% |
| Bvf Inc/IL | 8,650,158 | $233M | Unchanged |
| RA Capital Management | 7,636,813 | $205M | Reduced 0.52% |
| FMR | 5,977,045 | $161M | Added 16.37% |
| Rtw Investments | 5,933,815 | $160M | Unchanged |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is GHRS?
GH Research PLC Ordinary Shares (GHRS) is listed on Nasdaq, where it has traded since June 25, 2021.
Who are the largest institutional holders of GHRS?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of GHRS were Lynx1 Capital Management, Bvf Inc/IL and RA Capital Management.
How many institutions own GHRS?
61 institutions reported a position in GHRS for the quarter ended June 30, 2026, worth $1.4 billion in total.
Did institutions buy or sell GHRS last quarter?
Of the 5 largest reported holders, 2 added shares, 1 reduced its position and 2 held their positions unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for GHRS.
Every reported institutional holder, plus insider and congressional trades in GHRS, on SentiSense.